The optimal 5-fluorouracil regimen for the adjuvant therapy of colon cancer: Where to from here?

被引:5
作者
Michael, M [1 ]
Zalcberg, JR [1 ]
机构
[1] Peter MacCallum Canc Inst, Dept Med Oncol, Melbourne, Vic 3000, Australia
关键词
D O I
10.1023/A:1008378215303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:915 / 918
页数:4
相关论文
共 35 条
[1]   A ROLE FOR DIHYDROPYRIMIDINE DEHYDROGENASE AND THYMIDYLATE SYNTHASE IN TUMOR SENSITIVITY TO FLUOROURACIL [J].
BECK, A ;
ETIENNE, MC ;
CHERADAME, S ;
FISCHEL, JL ;
FORMENTO, P ;
RENEE, N ;
MILANO, G .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) :1517-1522
[2]   p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer [J].
Bouzourene, H ;
Gervaz, P ;
Cerottini, JP ;
Benhattar, J ;
Chaubert, P ;
Saraga, E ;
Pampallona, S ;
Bosman, FT ;
Givel, JC .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) :1008-1015
[3]  
Cascinu S, 1999, CLIN CANCER RES, V5, P1996
[4]   Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].
Cunningham, D ;
Pyrhönen, S ;
James, RD ;
Punt, CJA ;
Hickish, TF ;
Heikkila, R ;
Johannesen, TB ;
Starkhammar, H ;
Topham, CA ;
Awad, L ;
Jacques, C ;
Herait, P .
LANCET, 1998, 352 (9138) :1413-1418
[5]  
DEGRAMONT A, 1998, P AN M AM SOC CLIN, V17, pA985
[6]  
Edler D, 2000, CLIN CANCER RES, V6, P488
[7]   Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer [J].
Elsaleh, H ;
Joseph, D ;
Grieu, F ;
Zeps, N ;
Spry, N ;
Iacopetta, B .
LANCET, 2000, 355 (9217) :1745-1750
[8]   Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].
Erlichman, C ;
O'Connell, M ;
Kahn, M ;
Marsoni, S ;
Torri, V ;
Tardio, B ;
Zaniboni, A ;
Pancera, G ;
Martignoni, G ;
Labianca, R ;
Barni, A ;
Seitz, JF ;
Milan, C ;
Bedenne, L ;
Giovannini, M ;
Letreut, YP ;
Skillings, J ;
Shepard, L ;
Zee, B ;
Petrioli, R ;
Francini, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363
[9]   Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin:: Results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients [J].
Gamelin, É ;
Boisdron-Celle, M ;
Delva, R ;
Regimbeau, C ;
Cailleux, PE ;
Alleaume, C ;
Maillet, ML ;
Goudier, MJ ;
Sire, M ;
Person-Joly, MC ;
Maigre, M ;
Maillart, P ;
Fety, R ;
Burtin, P ;
Lortholary, A ;
Dumesnil, Y ;
Picon, L ;
Geslin, J ;
Gesta, P ;
Danquechin-Dorval, E ;
Larra, F ;
Robert, J .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1470-1478
[10]  
Gamelin EC, 1996, CANCER, V77, P441, DOI 10.1002/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO